WO2004041115A3 - Novel human elastases and stress urinary incontinence - Google Patents

Novel human elastases and stress urinary incontinence Download PDF

Info

Publication number
WO2004041115A3
WO2004041115A3 PCT/US2003/018696 US0318696W WO2004041115A3 WO 2004041115 A3 WO2004041115 A3 WO 2004041115A3 US 0318696 W US0318696 W US 0318696W WO 2004041115 A3 WO2004041115 A3 WO 2004041115A3
Authority
WO
WIPO (PCT)
Prior art keywords
urinary incontinence
stress urinary
novel human
elastases
human elastases
Prior art date
Application number
PCT/US2003/018696
Other languages
French (fr)
Other versions
WO2004041115A2 (en
Inventor
Leslie Kushner
Mahesh Mathrubutham
Srinivasa K Rao
Original Assignee
Long Island Jewish Res Inst
Leslie Kushner
Mahesh Mathrubutham
Srinivasa K Rao
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Long Island Jewish Res Inst, Leslie Kushner, Mahesh Mathrubutham, Srinivasa K Rao filed Critical Long Island Jewish Res Inst
Priority to AU2003299526A priority Critical patent/AU2003299526A1/en
Publication of WO2004041115A2 publication Critical patent/WO2004041115A2/en
Publication of WO2004041115A3 publication Critical patent/WO2004041115A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6448Elastases, e.g. pancreatic elastase (3.4.21.36); leukocyte elastase (3.4.31.37)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482Serine endopeptidases (3.4.21)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/966Elastase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Novel elastases are provided that are associated with stress urinary incontinence. Also provided are methods for determining whether a woman has stress urinary incontinence, and methods for treating or preventing stress urinary incontinence.
PCT/US2003/018696 2002-06-14 2003-06-12 Novel human elastases and stress urinary incontinence WO2004041115A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003299526A AU2003299526A1 (en) 2002-06-14 2003-06-12 Novel human elastases and stress urinary incontinence

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38909402P 2002-06-14 2002-06-14
US60/389,094 2002-06-14

Publications (2)

Publication Number Publication Date
WO2004041115A2 WO2004041115A2 (en) 2004-05-21
WO2004041115A3 true WO2004041115A3 (en) 2007-10-04

Family

ID=32312424

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/018696 WO2004041115A2 (en) 2002-06-14 2003-06-12 Novel human elastases and stress urinary incontinence

Country Status (2)

Country Link
AU (1) AU2003299526A1 (en)
WO (1) WO2004041115A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8834350B2 (en) 2006-06-16 2014-09-16 Ams Research Corporation Surgical implants, tools, and methods for treating pelvic conditions
US9283064B2 (en) 2005-07-26 2016-03-15 Ams Research Corporation Methods and systems for treatment of prolapse

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL163453A0 (en) * 2004-08-10 2009-02-11 Yeda Res & Dev Enzyme inhibitor in leukemia
US7740576B2 (en) 2005-04-05 2010-06-22 Ams Research Corporation Articles, devices, and methods for pelvic surgery
WO2007137226A2 (en) 2006-05-19 2007-11-29 Ams Research Corporation Method and articles for treatment of stress urinary incontinence

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHEN ET AL., NEUROLOGY AND URODYNAMICS, vol. 26, no. 2, 2007, pages 274 - 279 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9283064B2 (en) 2005-07-26 2016-03-15 Ams Research Corporation Methods and systems for treatment of prolapse
US8834350B2 (en) 2006-06-16 2014-09-16 Ams Research Corporation Surgical implants, tools, and methods for treating pelvic conditions

Also Published As

Publication number Publication date
AU2003299526A8 (en) 2004-06-07
WO2004041115A2 (en) 2004-05-21
AU2003299526A1 (en) 2004-06-07

Similar Documents

Publication Publication Date Title
AU2003276847A1 (en) Polymers, supersoft elastomers and methods for preparing the same
AP2004003026A0 (en) Methods for treating ocular neovascular diseases.
WO2004034990A3 (en) Methods and compositions for use in treating cancer
AU2002366641A1 (en) Methods for inhibiting ocular processes
WO2005117938A3 (en) Methods of treating ocular conditions
ZA200204312B (en) Laminate and process for its manufacture.
AU2001279654A1 (en) Copolymers and copolymer dispersions, method for the production thereof and their use
WO2004058153A9 (en) Methods and compositions for treating cancer using 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 21617, 39228, 49928, 54476.
AU2001265862A1 (en) Graft copolymers based on polyurethane, the production thereof and their use
AP2147A (en) A composition for treating aids and associated conditions.
AU2003214273A8 (en) Improved system for the treatment of stress urinary incontinence
AU2003247449A1 (en) Nano-ceramics and method thereof
WO2004018648A3 (en) Methods for treating patients and identifying therapeutics
WO2004041115A3 (en) Novel human elastases and stress urinary incontinence
AU2001251507A1 (en) Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death
AU2003292231A1 (en) Methods for diagnosing and treating schizophrenia
AU2003217471A1 (en) An automatic dispenser of hot pizzas and the like, and corresponding method of operation
ZA200110271B (en) Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylatic methods.
EP1572085A3 (en) Methods and compositions for treating and diagnosing diabetes
ZA200002546B (en) Sorbate-preserved compositions, method for the manufacture thereof and their use.
AU2001251508A1 (en) Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death
AU2001256998A1 (en) Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death
EP1511506A4 (en) Compositions and methods for preventing, treating and diagnosing diabetes
AU2002344103A1 (en) Combination determining device, and combination determining method and program
AU2001242507A1 (en) Method, diagnostic kit and microarray for determining the rhesus factor

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP